Correction: Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy. Iida M, Brand TM, Starr MM, Huppert EJ, Luthar N, Bahrar H, Coan JP, Pearson HE, Salgia R, Wheeler DL.Mol …
Correction: Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy. Iida M, Brand TM, Starr MM, Huppert EJ, Luthar N, Bahrar H, Coan JP, Pearson HE, Salgia R, Wheeler DL.Mol …